查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1624588

北美安瓿包裝：市場佔有率分析、產業趨勢與成長預測（2025-2030）

North America Ampoules Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 111 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

北美安瓿包裝市場規模預計到2025年為33億美元，預計2030年將達到42.6億美元，預測期內（2025-2030年）年複合成長率為5.29%。

北美安瓿包裝-市場-IMG1

主要亮點

  • 儘管北美製藥業比其他行業更成熟，但在創新和競爭方面正在經歷顯著成長，因此對安瓿包裝的需求預計將成長。日益成長的環境問題和醫療基礎設施支出的增加正在推動環保包裝解決方案的開發和創新。
  • 急慢性疾病患者數量的不斷增加，對安瓿包裝的需求產生了直接正面的影響。由於對無菌、防篡改、無反應和卓越性能的需求不斷成長，該市場預計將成長。
  • 加拿大對注射藥物的需求正在迅速增加，這極大地推動了市場的成長。對抗癌藥物、抗體偶聯物、類固醇和輸液等速效、高效價藥物的強勁需求預計將成為成長的主要動力。
  • 製藥業對無菌醫療包裝產品的需求不斷成長可能會推動預測期內的市場成長。 StatCan預測，2024年加拿大製藥和藥品製造業銷售額將達99.4億美元。
  • 歷史上，製造商利用玻璃來製造安瓿。然而，塑膠的廣泛使用和成本效益導致其採用量迅速增加，從而顯著降低了安瓿成本。與其他類型的安瓿相比，這種實惠的價格是其主要優勢。與多劑量替代品相比，消費者越來越喜歡單劑量注射包裝。根據食品藥物管理局(FDA) 的資料，在美國，單位劑量塑膠安瓿佔藥品包裝市場的近 24%。此外，它在金額方面有超越其他公司的勢頭，預計成長速度將高於平均水平。
  • 然而，對安瓿傾銷的擔憂正在阻礙市場擴張。塑膠對環境構成了重大挑戰，因為它們難以分解。安瓿製造中擴大使用綠色塑膠和生物分解性塑膠等永續材料，這預示著市場的成長。
  • 旨在提高國產藥品的完整性和品質的嚴格法律增加了玻璃在藥品包裝中的使用。製藥業對無菌醫療包裝的需求不斷成長預計將在預測期內推動市場成長。

北美安瓿包裝市場趨勢

醫藥終端用戶產業預計創紀錄成長

  • 製藥最終用戶產業的成長將推動安瓿市場。透過生物技術的發展引入注射療法正在推動這一領域的成長。由於該地區生物技術的發展和應用，以及對配備 RFID 標籤等先進技術的安瓿的需求增加，以防止藥品假冒的潛在威脅和成本，該細分市場也出現了成長。
  • 生產和研究活動的增加增加了對確保藥品安全和保護的法規的需求。因此，製造商正在與合約包裝商合作開發藥物附加檔，透過印刷和圖形傳達劑量和給藥資訊。
  • 根據 2024 年 2 月 IQVIA 報告，到 2027 年，北美藥品銷售額預計將達到約 9,920 億美元，鞏固其作為全球藥品銷售領先區域市場的地位。
  • 該地區的藥品銷售不斷成長，直接推動了對安瓿等包裝形式的需求。根據 IQVIA 2024 年 2 月報告，美國到 2023 年持續維持全球最大醫藥市場地位，收益超過 6,700 億美元。預計這些趨勢將有助於未來市場的成長。
  • 此外，消費者擴大選擇單劑量注射包裝而不是多劑量替代品。塑膠安瓿可進行計量給藥，使製藥公司能夠透過最大限度地減少藥物過量填充和簡化製造流程來更有效地控制成本。因此，塑膠安瓿對於處理高價值藥品的製藥公司特別有用。

預計美國將主導市場

  • 美國已成為全球玻璃安瓿包裝的主要市場，尤其是製藥業。美國經濟不斷成長，消費者在醫療保健和藥品方面的支出不斷增加，對玻璃包裝解決方案的需求不斷增加。此外，美國消費者越來越重視永續和環保的包裝。這些不斷變化的偏好促使製造商更青睞玻璃安瓿而不是塑膠安瓿。
  • 消費者、立法者、客戶和媒體都非常重視包裝的環保特性。玻璃是主要選擇，預計將推動美國市場的成長。美國零售聯合會最近的一項調查發現，美國和加拿大近 70% 的消費者重視品牌的永續性和環境友善性。
  • 美國許多製藥公司計劃採用玻璃安瓿實施更高產量比率和高速的填充線。例如，Labiana Pharmaceuticals 透過推出一系列新的液體安瓿並投資最先進的線上顆粒檢測設備來擴大其製造能力。此次擴建採用 Bausch & Strobel 的優質安瓿填充線，生產量為每小時 20,000 瓶。此外，我們還整合了專為線上生產而設計的 Pilastro RS1 最終光學偵測機，吞吐量高達每小時 12,000 件。
  • 製藥業主要涉及藥品的生產。這些藥物可診斷、治療、治癒和預防各種疾病。製藥業是全球最大的產業之一，全球市場價值超過1.2兆美元。世界頂尖製藥公司包括輝瑞（Pfizer）、默克（Merck）、強生（Johnson & Johnson）（皆位於美國）。因此，美國製藥業是世界上最大的製藥業之一。
  • 醫療保健支出的增加和政府對藥品包裝市場的資本投資也是市場成長的主要動力。根據醫療保險和醫療補助服務中心 (CMS) 的數據，美國醫療保健支出預計到 2023 年將達到 47,993 億美國，到 2032 年將達到 77,050 億美元。在技​​術創新、不斷成長的需求和策略聯盟的推動下，安瓿包裝市場處於良好的成長態勢。

北美安瓿包裝產業概況

北美安瓿包裝市場是半靜態的，少數供應商佔了很大比例。市場參與企業正在尋找新的方法來形成策略聯盟和合作，以創新並推動該地區安瓿包裝市場的發展。

  • 2023 年 10 月 玻璃先驅肖特推出下一代 I 型硼矽酸玻璃管，以滿足製藥業不斷變化的需求。這種創新產品和相關服務符合三個關鍵的行業趨勢：提高製藥複雜性、解決永續性和提高數位化。製藥轉換器利用肖特玻璃管生產優質管瓶、安瓿、注射器和藥筒。
  • 2023年3月，拜耳股份公司宣布計劃在美國投資10億美元進行藥物研發，目標是讓其在美國的銷售額加倍，並在10年內成為該國頂級製藥公司。拜耳公司美國製藥業務總裁Sebastian Guth表示，該公司過去三年將其製藥業務行銷部門的美國員工數量增加了約50%，到2030年將增加美國員工數量預計將增加約 75%。

其他好處：

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

目錄

第1章簡介

  • 研究假設和市場定義
  • 調查範圍

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 產業價值鏈分析
  • 產業吸引力－波特五力分析
    • 供應商的議價能力
    • 消費者議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間敵對關係的強度
  • 市場促進因素
    • 製藥業對無菌包裝解決方案的需求增加
  • 市場限制因素
    • 對傾倒使用過的安瓿的擔憂

第5章市場區隔

  • 材料
    • 玻璃
    • 塑膠
  • 最終用戶產業
    • 藥品
    • 個人護理和化妝品
  • 國家名稱
    • 美國
    • 加拿大

第6章 競爭狀況

  • 公司簡介
    • SCHOTT AG
    • Gerresheimer AG
    • Nipro Pharma Packaging International NV
    • DWK Life Sciences
    • Stevanato Group
    • Accu-Glass LLC
    • VWR International LLC.
    • SGD Pharma

第7章 投資分析

第8章 市場機會及未來趨勢

簡介目錄
Product Code: 46548

The North America Ampoules Packaging Market size is estimated at USD 3.30 billion in 2025, and is expected to reach USD 4.26 billion by 2030, at a CAGR of 5.29% during the forecast period (2025-2030).

North America Ampoules Packaging - Market - IMG1

Key Highlights

  • The demand for ampoule packaging is expected to grow as the pharmaceutical industry in North America is growing significantly in terms of innovation and competitiveness despite its mature status compared to other areas. A rise in environmental concerns and increasing spending on healthcare infrastructure has sparked the development and innovation of eco-friendly packing solutions.
  • The growth in patients with acute and chronic illnesses has directly and positively impacted the demand for ampoule packaging. The market is expected to grow due to the rise in demand for sterile, tamper-proof, and non-reactive items with excellent performance.
  • Canada's surging demand for injectable pharmaceuticals is significantly boosting the market's growth. The strong demand for oncology treatments and other high-potency drugs, like antibody conjugates, steroids, and IV fluids that necessitate a rapid onset of action, is anticipated to be the primary growth catalyst.
  • The rising demand for sterile medical packaging products from pharmaceutical industries is set to propel the growth of the market during the forecast period. StatCan projects that in 2024, the revenue from Canada's pharmaceutical and medicine manufacturing industry will reach USD 9.94 billion.
  • Historically, manufacturers have relied on glass to produce ampoules. However, with the widespread availability and cost-effectiveness of plastic, its adoption has surged, significantly driving down ampoule costs. This affordability stands out as a key advantage of plastic ampoules compared to their counterparts. Consumers increasingly favor unit-dose parenteral packaging over multi-dose alternatives. In the United States, data from the Food and Drug Administration (FDA) indicates that unit-dose plastic ampoules constitute nearly 24% of the pharmaceutical packaging market. Furthermore, they are poised to outpace others in terms of value, presenting above-average growth prospects.
  • However, concerns over ampoule dumping are hindering the expansion of the market. Given that plastics are not easily decomposed, they pose significant environmental challenges. The rising use of sustainable materials, like green or biodegradable plastics, in ampoule production bodes well for the market's growth.
  • Stringent legislation aimed at enhancing the integrity and quality of domestically produced pharmaceuticals has led to increased use of glass in pharmaceutical packaging. The rising demand for sterile medical packaging in the pharmaceutical industry is projected to drive market growth during the forecast period.

North America Ampoules Packaging Market Trends

The Pharmaceutical End-user Industry is Expected to Record Growth

  • The growing pharmaceutical end-user industry drives the ampoule market. The introduction of injectable therapies through the development of biotechnology is driving the growth of the segment. The segment is also expected to grow due to the development of biotechnologies and their applications in the region, along with increasing demand for ampoules with advanced technologies like RFID tags to protect against potential threats and costs of drug counterfeiting.
  • The increasing manufacturing and research activities are raising the demand for regulations to ensure drug safety and protection. Hence, manufacturers are collaborating with contract packagers to develop drug adherence packages that communicate dosage information through print and graphics.
  • According to the IQVIA report in February 2024, North America's pharmaceutical sales are expected to reach approximately USD 992 billion by 2027, solidifying its position as the leading regional market in global pharma sales.
  • Pharmaceutical sales are growing in the region and are directly contributing to the demand for packaging formats like ampoules. According to a February 2024 report by IQVIA, the United States maintained its position as the world's largest pharmaceutical market in 2023, raking in over USD 670 billion in revenue. Such trends are expected to contribute to market growth in the future.
  • Furthermore, consumers are increasingly opting for unit-dose parenteral packaging instead of multi-dose alternatives. Plastic ampoules, offering fixed dosages, enable pharmaceutical companies to manage costs more effectively by minimizing drug overfill and streamlining production processes. As a result, plastic ampoules are particularly beneficial for pharmaceutical firms handling high-value medications.

The United States Expected to Dominate the Market

  • The United States stands as the leading global market for packaging, particularly in terms of glass ampoules for the pharmaceutical industry. With the US economy on a growth trajectory, consumer spending on healthcare and medicines is increasing, subsequently bolstering the demand for glass packaging solutions. Moreover, American consumers are increasingly prioritizing sustainable and environmentally friendly packaging. This shift in preference is prompting manufacturers to favor glass ampoules over their plastic counterparts.
  • Consumers, legislators, customers, and the media alike are placing heightened emphasis on packaging's environmental attributes. Glass, being the primary choice, is anticipated to propel the growth of the market in the United States. A recent study by the National Retail Federation highlighted that almost 70% of consumers in both the United States and Canada value sustainability and eco-friendliness in brands.
  • Many pharmaceutical companies in the United States are set to see enhanced yields from glass ampoules and the introduction of high-speed filling lines. For example, Labiana Pharmaceuticals expanded its manufacturing capabilities by launching a new range of liquid ampoules and investing in state-of-the-art equipment for in-line particle detection. Its expansion features a premium ampoule filling line from Bausch & Strobel, boasting a production capacity of 20,000 ampoules per hour. Additionally, it integrated a Pilastro RS1 final optical inspection machine, designed for in-line production with a throughput of up to 12,000 units per hour.
  • The pharmaceutical industry is mainly concerned with the production of pharmaceutical drugs. These drugs diagnose, treat, cure, or prevent various diseases. The pharmaceutical industry is one of the largest in the world, with a global market value of more than USD 1.2 trillion. Top global pharmaceutical companies include Pfizer, Merck, and Johnson & Johnson (all based in the United States). As a result, the pharmaceutical industry in the United States is among the largest in the world.
  • Increasing healthcare spending and the government's capital investment in the pharmaceutical packaging market are also major drivers of market growth. According to the US Centers for Medicare and Medicaid Services (CMS), healthcare spending in the United States reached USD 4,799.3 billion in 2023, and it is projected to reach USD 7705 billion by 2032. The ampoules packaging market, driven by technological innovation, growing demand, and strategic collaborations, is well-positioned to experience growth.

North America Ampoules Packaging Industry Overview

The ampoule packaging market in North America is semi-consolidated due to the presence of a few vendors holding significant market shares. The market players are finding new ways, such as strategic partnerships or collaborations, to innovate the development of ampoule packaging in the region, fostering growth.

  • October 2023: Glass pioneer SCHOTT unveiled its next-generation type I borosilicate glass tubing, tailored to address the evolving demands of the pharmaceutical industry. This innovative product and its accompanying services align with three pivotal industry trends: the increasing complexity of pharmaceuticals, a commitment to sustainability, and the push toward digitalization. Pharmaceutical converters utilize SCHOTT's glass tubing to manufacture premium vials, ampoules, syringes, and cartridges, adept at storing everything from straightforward medications to intricate, high-complexity drugs.
  • March 2023: Bayer AG announced plans to invest USD 1 billion in drug R&D in the United States, aiming to double its US sales by the end of the decade, making it the top pharmaceutical company in the country. According to Sebastian Guth, President of Bayer's pharmaceuticals business in the United States, the company increased the number of US employees working on the marketing of its pharmaceutical business by about 50% over the past three years, which is expected to further increase by about 75% by 2030.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Industry Value-Chain Analysis
  • 4.3 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Suppliers
    • 4.3.2 Bargaining Power of Consumers
    • 4.3.3 Threat of New Entrants
    • 4.3.4 Threat of Substitute Products
    • 4.3.5 Intensity of Competitive Rivalry
  • 4.4 Market Driver
    • 4.4.1 Increasing Demand for Sterile Packaging Solutions for the Pharmaceutical Industry
  • 4.5 Market Restraint
    • 4.5.1 Concerns Regarding Dumping of Used Ampoules

5 MARKET SEGMENTATION

  • 5.1 Material
    • 5.1.1 Glass
    • 5.1.2 Plastic
  • 5.2 End-User Industry
    • 5.2.1 Pharmaceutical
    • 5.2.2 Personal Care and Cosmetic
  • 5.3 Country
    • 5.3.1 United States
    • 5.3.2 Canada

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 SCHOTT AG
    • 6.1.2 Gerresheimer AG
    • 6.1.3 Nipro Pharma Packaging International NV
    • 6.1.4 DWK Life Sciences
    • 6.1.5 Stevanato Group
    • 6.1.6 Accu-Glass LLC
    • 6.1.7 VWR International LLC.
    • 6.1.8 SGD Pharma

7 INVESTMENT ANALYSIS

8 MARKET OPPORTUNITIES AND FUTURE TRENDS